ETV6
Transcription factor ETV6
Also known as: ETV6_HUMAN, TEL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P41212
- Gene
- ETV6
- Ensembl
- ENSG00000139083
- Chromosome
- 12
- Canonical length
- 452 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoli,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes an ETS family transcription factor. The product of this gene contains two functional domains: a N-terminal pointed (PNT) domain that is involved in protein-protein interactions with itself and other proteins, and a C-terminal DNA-binding domain. Gene knockout studies in mice suggest that it is required for hematopoiesis and maintenance of the developing vascular network. This gene is known to be involved in a large number of chromosomal rearrangements associated with leukemia and congenital fibrosarcoma. [provided by RefSeq, Sep 2008]
Canonical amino-acid sequenceUniProt
452 residues, UniProt reviewed canonical sequence.
>P41212|ETV6
1 MSETPAQCSI KQERISYTPP ESPVPSYASS TPLHVPVPRA LRMEEDSIRL PAHLRLQPIY
61 WSRDDVAQWL KWAENEFSLR PIDSNTFEMN GKALLLLTKE DFRYRSPHSG DVLYELLQHI
121 LKQRKPRILF SPFFHPGNSI HTQPEVILHQ NHEEDNCVQR TPRPSVDNVH HNPPTIELLH
181 RSRSPITTNH RPSPDPEQRP LRSPLDNMIR RLSPAERAQG PRPHQENNHQ ESYPLSVSPM
241 ENNHCPASSE SHPKPSSPRQ ESTRVIQLMP SPIMHPLILN PRHSVDFKQS RLSEDGLHRE
301 GKPINLSHRE DLAYMNHIMV SVSPPEEHAM PIGRIADCRL LWDYVYQLLS DSRYENFIRW
361 EDKESKIFRI VDPNGLARLW GNHKNRTNMT YEKMSRALRH YYKLNIIRKE PGQRLLFRFM
421 KTPDEIMSGR TDRLEHLESQ ELDEQIYQED ECLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ETV6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 39 nTPM
- salivary gland: 31 nTPM
- blood vessel: 27 nTPM
- skin: 22 nTPM
- breast: 19 nTPM
- thymus: 16 nTPM
Single-cell type
- hematopoietic stem cells: 1,563 nCPM
- lacrimal acinar cells: 1,323 nCPM
- thymocytes: 1,200 nCPM
- neutrophils: 1,149 nCPM
- megakaryocyte-erythroid progenitors: 1,117 nCPM
- salivary acinar cells: 1,047 nCPM
Immune cell
- neutrophil: 9.9 nTPM
- non-classical monocyte: 6.8 nTPM
- basophil: 6.2 nTPM
- eosinophil: 5.9 nTPM
- intermediate monocyte: 5.6 nTPM
- plasmacytoid DC: 5.3 nTPM
Brain region
- medulla oblongata: 20 nTPM
- thalamus: 15 nTPM
- spinal cord: 15 nTPM
- white matter: 14 nTPM
- pons: 14 nTPM
- midbrain: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ETV6.
Disease | AllUniProt
Conditions ETV6 is implicated in, by any mechanism.
- Myeloproliferative disorder chronic with eosinophilia (MPE) MIM:131440
- Leukemia, acute myelogenous (AML) MIM:601626
- Thrombocytopenia 5 (THC5) MIM:616216
Disease | GeneticClinVar
59 pathogenic / likely-pathogenic of 926 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Inborn genetic diseases
- Thrombocytopenia 5
- Thrombocytopenia
- ETV6-related disorder
- Acute myeloid leukemia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.32
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 1.78
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- hematopoietic stem cell proliferation
- mesenchymal cell apoptotic process
- negative regulation of transcription by RNA polymerase II
- neurogenesis
- regulation of transcription by RNA polymerase II
- vitellogenesis
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- protein domain specific binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ETV6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ETV6 as an antibody target. Whether an autoantibody or antibody against ETV6 could matter depends on whether native ETV6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ETV6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ETV6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...